These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12801794)

  • 1. Tumor markers: discovery to practice.
    Zhang WW
    Drug Discov Today; 2003 May; 8(10):441-3. PubMed ID: 12801794
    [No Abstract]   [Full Text] [Related]  

  • 2. Discovery and development of biomarkers of neurological disease.
    Dunckley T; Coon KD; Stephan DA
    Drug Discov Today; 2005 Mar; 10(5):326-34. PubMed ID: 15749281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond the genome--SMi Conference 27-28 January 2003, London, UK.
    Swinton J; Sheridan JM; Henning SW
    IDrugs; 2003 Mar; 6(3):203-6. PubMed ID: 12838986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. When drugs development meets genomics.
    Leung YF; Lam DS; Pang CP
    Pharmacogenomics J; 2001; 1(4):237-8. PubMed ID: 11908765
    [No Abstract]   [Full Text] [Related]  

  • 5. Methods for the identification of vascular markers in health and disease: from the bench to the clinic.
    Roesli C; Neri D
    J Proteomics; 2010 Oct; 73(11):2219-29. PubMed ID: 20541635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In biomarkers we trust?
    Baker M
    Nat Biotechnol; 2005 Mar; 23(3):297-304. PubMed ID: 15765081
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug discovery and development using chemical genomics.
    Sehgal A
    Curr Opin Drug Discov Devel; 2002 Jul; 5(4):526-31. PubMed ID: 12197310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in molecular targets and cancer therapeutics.
    Westwell AD
    Drug Discov Today; 2004 Mar; 9(5):207-9. PubMed ID: 14980538
    [No Abstract]   [Full Text] [Related]  

  • 9. Will genomics revolutionise pharmaceutical R&D?
    Noble D
    Trends Biotechnol; 2003 Aug; 21(8):333-7. PubMed ID: 12902169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enabling parallel protein analysis through mass spectrometry.
    Domon B; Alving K; He T; Ryan TE; Patterson SD
    Curr Opin Mol Ther; 2002 Dec; 4(6):577-86. PubMed ID: 12596360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vita Genomics, Inc.
    Shih-Hsin Wu L; Su CL; Chen E
    Pharmacogenomics; 2007 Jun; 8(6):669-73. PubMed ID: 17559355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New technologies for biomarker discovery in multiple sclerosis.
    Comabella M; Racke MK
    J Neuroimmunol; 2012 Jul; 248(1-2):1. PubMed ID: 22726889
    [No Abstract]   [Full Text] [Related]  

  • 13. Novel initiative seeks genetic causes of diabetes risk.
    Ratner M
    Nat Rev Drug Discov; 2004 Dec; 3(12):987. PubMed ID: 15645600
    [No Abstract]   [Full Text] [Related]  

  • 14. Streamlining drug discovery: finding the right drug against the right target to treat the right disease.
    Ng JH; Ilag LL
    Drug Discov Today; 2004 Jan; 9(2):59-60. PubMed ID: 15025066
    [No Abstract]   [Full Text] [Related]  

  • 15. Genomics and proteomics tools for compound mode-of-action studies in drug discovery.
    Kley N; Ivanov I; Meier-Ewert S
    Pharmacogenomics; 2004 Jun; 5(4):395-404. PubMed ID: 15165175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In the pursuit of industrial proteomics.
    Mitchell P
    Nat Biotechnol; 2003 Mar; 21(3):233-7. PubMed ID: 12610565
    [No Abstract]   [Full Text] [Related]  

  • 17. Towards identification of true cancer biomarkers.
    Diamandis EP
    BMC Med; 2014 Sep; 12():156. PubMed ID: 25220599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomics approach to illustrate drug action mechanisms.
    Wang Y; Chiu JF; He QY
    Curr Drug Discov Technol; 2006 Sep; 3(3):199-209. PubMed ID: 17311565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iconix Biosciences, Inc.
    Fielden MR; Halbert DN
    Pharmacogenomics; 2007 Apr; 8(4):401-5. PubMed ID: 17391077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. siRNAs in drug discovery: target validation and beyond.
    Natt F
    Curr Opin Mol Ther; 2007 Jun; 9(3):242-7. PubMed ID: 17608022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.